Charles River Labs upgraded to Buy from Hold at Jefferies Jefferies upgraded Charles River Labs citing valuation and a rebound in R&D spending. The firm raised its price target for shares to $50 from $41.
News For CRL From The Last 14 Days
Check below for free stories on CRL the last two weeks.